It's been cumbersome for physicians to access unapproved drugs: FDA cancer drug czar

CNBC's Meg Tirrell talks to Rick Pazdur, director of the FDA's Oncology Center of Excellence, at the ASCO conference about the drug approval process and how the agency is trying to make it easier for patients to access new treatments.
Mon, Jun 3 20191:27 PM EDT